Sono-Tek Corporation (SOTK) Q2 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary reveals strong financial performance, successful market penetration in China, and strategic expansion into new markets. The Q&A section highlights positive analyst sentiment, with confidence in growth potential across various sectors. Despite management's lack of concrete guidance, the optimistic outlook for revenue and market expansion suggests a positive sentiment. The absence of negative trends or risks further supports this positive assessment.
Key Financial Performance
First Half Revenue $10.3 million, a new record high, with modest annual revenue growth. Reasons include strong sales in the medical device industry and clean energy sector.
Net Income (First Half) $917,000, up 36% from the previous year. Reasons include higher gross profit and lower operating expenses.
Second Quarter Revenue $5.16 million, slightly up year-over-year and sequentially. Reasons include a favorable product mix and strong sales in the medical device industry.
Gross Profit (Second Quarter) $2.6 million, up 3% year-over-year. Reasons include a favorable product mix of mature high ASP systems and reduced costs.
Net Income (Second Quarter) $431,000, up 27% year-over-year. Reasons include higher gross profit and lower operating expenses.
Medical Market Sales (Second Quarter) $1 million, up 150% year-over-year. Reasons include strong demand for balloon coating systems in the U.S., Europe, and China.
Alternative Clean Energy Sales (Second Quarter) $2.43 million, down 3% year-over-year. Reasons include slowing momentum in the U.S. clean energy industry.
Electronics Market Sales (Second Quarter) $1.46 million, down 1% year-over-year. Reasons include timing for similar machines.
Industrial Market Sales (Second Quarter) $288,000, down 68% year-over-year. Reasons include a large FY 2025 European glass coating order that didn't repeat.
Gross Profit (First Half) $5.3 million, up 6% year-over-year. Reasons include product mix and favorable warranty expenses.
Operating Income (First Half) $905,000, up 72% year-over-year. Reasons include stronger gross profit and decreased operating expenses.
Medical Market Sales (First Half) $1 million, up 44% year-over-year. Reasons include strong balloon coating systems sales in the U.S., Europe, and China.
Alternative Energy Sales (First Half) $901,000, up 90% year-over-year. Reasons include shipment of 6 high ASP solar coating systems.
Electronics Market Sales (First Half) Down 21% year-over-year. Reasons include strong FY 2025 semiconductor sales and FY 2026 timing for similar machines.
Industrial Market Sales (First Half) Down 67% year-over-year. Reasons include a large FY 2025 European glass coating order that didn't repeat.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
High ASP Systems: Shift to larger, more complex systems with prices exceeding $300,000, reaching up to $1 million or more. This has significantly increased average unit selling price and broadened the addressable market.
Medical Device Industry: Strong momentum with increased demand for high-volume production systems and balloon catheter coating machines. Recent large orders include $5 million and $2.8 million from U.S. medical device manufacturers.
Clean Energy Sector: Continued focus on next-generation solar cells, fuel cells, green hydrogen generation, and carbon capture applications. However, a decline in clean energy orders is anticipated this year.
Geographic Sales: Sales in Asia increased by 153% year-over-year, driven by growth in China and other parts of Asia. EMEA sales increased by 25%, while U.S. and Canada sales decreased by 22% due to slowing clean energy momentum.
Diversification Strategy: Diversification into medical and semiconductor markets is helping offset declines in clean energy. Strong growth in medical device industry sales, particularly in balloon catheter coating systems.
Revenue Growth: Achieved record first-half revenue of $10.3 million, marking the sixth consecutive quarter with revenue over $5 million. Net income increased by 36% year-over-year to $917,000.
Backlog and Financial Position: Solid backlog of $11.2 million and a strong balance sheet with $10.6 million in cash and no debt. Investments in R&D totaled $1.3 million for the first half.
Strategic Shift to Complex Systems: Focus on larger, customized systems with higher ASPs, targeting diverse industries such as medical devices, clean energy, and semiconductors.
Clean Energy and Medical Focus: Shift towards clean energy and medical device markets, with significant investments in R&D and product enhancements to support these sectors.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Trade Issues: Sono-Tek faces potential risks from changes in relationships with trading partners and the redirection of climate policy and related government spending. While the company builds key ultrasonic hardware in the U.S. and sources materials domestically, it is exposed to tariffs in certain countries, which could impact export sales depending on negotiation outcomes.
Clean Energy Sector Decline: The company anticipates a decline in clean energy orders this year, which could impact revenue. This is partially mitigated by diversification into other sectors, but the slowdown in clean energy momentum, particularly in the U.S., remains a concern.
Customer-Requested Shipment Delays: Unplanned shipment delays requested by customers have impacted revenue timing, moving some sales into future quarters. This creates uncertainty in revenue recognition and operational planning.
Geographic Sales Variability: Sales in the U.S. and Canada decreased by 22% year-over-year, driven by slowing momentum in the clean energy industry. While this was offset by growth in Asia and EMEA, the variability in geographic sales poses a challenge to consistent revenue growth.
Product Division Fluctuations: The company experienced declines in certain product categories, such as multi-access coating systems and industrial market sales, influenced by non-repeating large orders from previous fiscal years. This highlights the risk of dependency on large, one-time orders.
Government Policy Shifts: Shifts in U.S. government clean energy and tariff policies create uncertainty for the company’s clean energy and export-related sales. This could impact future demand and revenue stability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: The company has updated its guidance to reflect modest revenue growth for the full fiscal year 2026. This is balanced against market adjustments due to shifts in government clean energy and tariff policies, with positive offsets expected from growing demand in the medical device industry.
Clean Energy Sector: A decline in clean energy orders is anticipated for the year. However, the company remains optimistic about potential future demand depending on customers' execution of expansion plans.
Medical Device Industry: Strong momentum is observed in the medical device industry, with growing interest in high-volume production systems and increased demand for balloon catheter coating machines. This sector is expected to positively offset declines in other areas.
Diversification Strategy: The company’s diversification strategy is helping to mitigate potential declines in specific sectors, supported by enhancements to equipment across all sectors, including new expanded features and functionalities.
Backlog and Financial Position: The company has a solid backlog of $11.2 million and a strong balance sheet with $10.6 million in cash and no debt, supporting its growth outlook.
Product Development: Investments in R&D and product expansion are expected to drive long-term growth, with a focus on larger, more complex systems and platforms for production applications.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Interest and Dividend Income: Interest and dividend income remained steady at $82,000 in the second quarter that compares with $85,000 in the prior year's quarter. Our present investment policy is to invest excess cash in highly liquid low-risk U.S. treasury securities. At August 31, 2025, the majority of our holdings were rated at or above investment grade.
Interest and Dividend Income for First Half: In the first half of fiscal 2026, interest and dividend income decreased by $4,000 to $224,000 and that compares with $228,000 in the first half of fiscal 2025.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the competitive dynamic for Sono-Tek in the Chinese medical device market?
A:Sono-Tek has been able to capture significant orders in the Chinese medical device market despite competition from local copycat ultrasonic coating vendors. Chinese manufacturers have chosen Sono-Tek's systems due to their superior quality, even at 3-4 times the price of local alternatives. This is particularly critical in the medical device industry where defects can have severe consequences. Sono-Tek's systems are one generation behind their most advanced systems to protect proprietary technology.
Q:Are the customers in China Western companies manufacturing there or Chinese entities?
A:The customers in this case are Chinese manufacturers, which is unusual as it is more common for Western entities manufacturing in China to buy Sono-Tek systems. These Chinese manufacturers are choosing Sono-Tek despite the Chinese government's push to buy domestically made products, as local technologies do not meet the required standards.
Q:Does Sono-Tek have exposure to balloon catheter manufacturing outside of China?
A:Yes, Sono-Tek is seeing global interest in balloon catheter manufacturing, similar to their dominance in the stent manufacturing market. They are capturing major leaders in this niche, and the interest is snowballing geographically across Japan, China, Europe, and the U.S. This niche is in its early stages, offering significant growth potential.
Q:How does the balloon catheter market compare to the stent market for Sono-Tek?
A:The balloon catheter market is similar to the stent market, but Sono-Tek now offers more sophisticated platforms with higher ASPs (average selling prices) and integrated capabilities. This has led to higher customer satisfaction and improved gross margins. Sono-Tek aims to replicate its success in the stent market across other medical device markets.
Q:What is Sono-Tek's strategy for application engineering and forward deployed engineering (FDE)?
A:Sono-Tek has expanded its application engineering group into a forward deployed engineering (FDE) model. This involves embedding experienced engineers directly in customer production environments to optimize systems and strengthen partnerships. This approach accelerates system adoption, shortens sales cycles, and uncovers new opportunities within existing accounts. It also supports pricing power and margin expansion.
Q:What are the key performance indicators (KPIs) for the FDE group?
A:Sono-Tek tracks the percentage of revenue tied to laboratory testing and application development (currently 60-70%) and revenue from high ASP systems (roughly 2/3 of total sales). Almost all large systems pass through the FDE group. Margin benefits are expected to build over the next 1-2 years as more large accounts move into full-scale production.
Q:How does the FDE model affect Sono-Tek's competitive position?
A:The FDE model differentiates Sono-Tek by elevating its role from equipment supplier to technology partner. This supports strong pricing power, deeper account penetration, and recurring revenue opportunities. It also leads to margin expansion as high ASP machines become more developed.
Q:What is the significance of Sono-Tek's recent wins in the optics-related OEM market?
A:The recent wins in the optics-related OEM market are significant for Sono-Tek's long-term market entry strategy. These partnerships provide valuable industry knowledge and accelerate entry into new applications. While not immediately significant in revenue, they hold long-term potential for market expansion.
Q:What is the outlook for Sono-Tek in the semiconductor market?
A:Sono-Tek is seeing strong interest in the semiconductor market, particularly after a successful trade show. The company is expanding its product line to address 300-millimeter fab environments, which represent a significant growth opportunity. This shift is expected to result in higher ASP machines and long-term growth.
Q:What is the timeline for recognizing revenue from Sono-Tek's backlog?
A:The largest recent orders will mostly be recognized in FY 2027, with 10-15% of the revenue expected in the current fiscal year. The build time for these machines is significant, so the bulk of the revenue will be realized next year.
Q:Will Sono-Tek's second-half sales be weighted towards the third or fourth quarter?
A:Second-half sales are expected to be slightly more weighted towards the third quarter due to a system delivery that was pushed into Q3 at the customer's request.
Q:Can Sono-Tek achieve $6 million to $8 million in quarterly revenue?
A:While no formal projections were given, management expressed optimism and would be disappointed if they do not achieve this milestone.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer to the question about achieving $6 million to $8 million in quarterly revenue, stating they would be disappointed if they do not achieve it but offering no formal projections.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Bagley Chief
Canada sale
China energy
Europe China
FY glass
FY semiconductor
Sono Tek
balance caution
balloon coating
category
caution market
coating order
demand device
device industry
diversification
electronics market
energy industry
energy tariff
industry sale
line coating
market FY
market balloon
market shift
momentum energy
order device
period income
place
policy demand
sale Asia
sale Latin
sale momentum
sale shipment
sheet cash
shift government
strength
system Europe
system customer
tariff policy
SOTK Transcript
Sono-Tek Corporation (SOTK) Q2 2026 Earnings Call Transcript
Positive10-14
The earnings call summary reveals strong financial performance, successful market penetration in China, and strategic expansion into new markets. The Q&A section highlights positive analyst sentiment, with confidence in growth potential across various sectors. Despite management's lack of concrete guidance, the optimistic outlook for revenue and market expansion suggests a positive sentiment. The absence of negative trends or risks further supports this positive assessment.
Earnings call transcript: Sono-Tek Corp’s Q2 2025 results meet expectations
Unknown5-28
The earnings call presents a mixed outlook: strong growth in certain sectors like clean energy and medical devices, offset by weak demand in China and a decline in Latin America sales. The Q&A reveals some concerns about softening demand and unclear management responses on tariffs and order improvements. Despite a strong backlog and no debt, the decline in earnings per share and lack of clear guidance tempers optimism. These factors suggest a neutral stock price movement over the next two weeks.
Sono-Tek Corporation (SOTK) Q4 2025 Earnings Call Transcript
Unknown5-28
The financial performance shows mixed results with slight growth in net sales but decreased operating income and net income. The share buyback program and strong cash position are positives, but geographic risks and demand softening in the clean energy sector are concerns. The Q&A reveals uncertainty in demand and management's unclear responses on tariffs and buybacks. The strong backlog and potential in medical and semiconductor sectors provide some optimism, but overall, the sentiment remains neutral due to mixed signals and lack of clear guidance.
Sono-Tek Corporation (SOTK) Q2 2025 Earnings Call Transcript
Unknown10-15
The earnings call presents mixed signals: while there are positive developments such as increased sales in alternative energy and a strong cash position, there are significant negatives like declining sales in key regions, reduced operating income, and no shareholder return plan. The Q&A section revealed uncertainty in growth projections and highlighted challenges in demand fluctuations. Despite some optimism in product transitions and backlog fulfillment, the lack of clear guidance and regional sales declines result in a neutral sentiment, indicating little expected stock movement in the next two weeks.
SOTK Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
